Clinical Trials Directory

Trials / Terminated

TerminatedNCT05167422

Trusted Messenger Intervention

Preliminary Study of a Trusted Messenger Intervention to Promote Vaccine Uptake in Adult Inpatient Psychiatric Hospitals

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
2 (actual)
Sponsor
Dartmouth-Hitchcock Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this pilot study is to develop and evaluate test a trusted messenger intervention targeting vaccine hesitancy in patients on an inpatient psychiatric hospital setting with both acute and chronic patients.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTrusted MessengerA nested waitlist design in which patients and staff are nested within two inpatient psychiatric units. New Hampshire Hospital staff will be trained to deliver the trusted messenger intervention up to 24 patients on the first unit while the second unit receives care as usual, during which time in-house vaccinations among patients on both units will be tracked in a registry. After a 3-week study period, up to 24 patients on the second unit will receive the trusted messenger intervention and followed for a period of 3 weeks. The trusted messenger intervention will consist of staff who are trained to engage patients informally and assist building social norms for vaccine uptake supported by weekly and as-needed check-ins with a content expert who can answer specific vaccine related questions over a 3 week period.

Timeline

Start date
2021-09-14
Primary completion
2023-07-14
Completion
2023-07-14
First posted
2021-12-22
Last updated
2023-07-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05167422. Inclusion in this directory is not an endorsement.

Trusted Messenger Intervention (NCT05167422) · Clinical Trials Directory